| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3592249
[patent_doc_number] => 05521172
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-28
[patent_title] => 'Methods for lowering serum cholesterol'
[patent_app_type] => 1
[patent_app_number] => 8/515339
[patent_app_country] => US
[patent_app_date] => 1995-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9934
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 395
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/521/05521172.pdf
[firstpage_image] =>[orig_patent_app_number] => 515339
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/515339 | Methods for lowering serum cholesterol | Aug 14, 1995 | Issued |
Array
(
[id] => 3533995
[patent_doc_number] => 05556876
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-17
[patent_title] => 'Methods for lowering serum cholesterol'
[patent_app_type] => 1
[patent_app_number] => 8/515346
[patent_app_country] => US
[patent_app_date] => 1995-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9933
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 372
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/556/05556876.pdf
[firstpage_image] =>[orig_patent_app_number] => 515346
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/515346 | Methods for lowering serum cholesterol | Aug 14, 1995 | Issued |
Array
(
[id] => 3787875
[patent_doc_number] => 05840731
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Pain-alleviating drug composition and method for alleviating pain'
[patent_app_type] => 1
[patent_app_number] => 8/510546
[patent_app_country] => US
[patent_app_date] => 1995-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3091
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840731.pdf
[firstpage_image] =>[orig_patent_app_number] => 510546
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/510546 | Pain-alleviating drug composition and method for alleviating pain | Aug 1, 1995 | Issued |
| 08/508775 | COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY DISORDERS | Jul 27, 1995 | Abandoned |
Array
(
[id] => 3649465
[patent_doc_number] => 05639792
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-17
[patent_title] => 'No synthetase inhibitors as medicinal products intended to reduce alcohol consumption or to prevent excessive alcohol consumption'
[patent_app_type] => 1
[patent_app_number] => 8/507815
[patent_app_country] => US
[patent_app_date] => 1995-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 1884
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/639/05639792.pdf
[firstpage_image] =>[orig_patent_app_number] => 507815
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/507815 | No synthetase inhibitors as medicinal products intended to reduce alcohol consumption or to prevent excessive alcohol consumption | Jul 26, 1995 | Issued |
Array
(
[id] => 3665508
[patent_doc_number] => 05597815
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-28
[patent_title] => 'Prevention of hyperphosphatemia in kidney disorder patients'
[patent_app_type] => 1
[patent_app_number] => 8/502288
[patent_app_country] => US
[patent_app_date] => 1995-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 5400
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/597/05597815.pdf
[firstpage_image] =>[orig_patent_app_number] => 502288
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/502288 | Prevention of hyperphosphatemia in kidney disorder patients | Jul 12, 1995 | Issued |
Array
(
[id] => 3646766
[patent_doc_number] => 05637581
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-10
[patent_title] => 'Preparations containing 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines'
[patent_app_type] => 1
[patent_app_number] => 8/500001
[patent_app_country] => US
[patent_app_date] => 1995-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3200
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/637/05637581.pdf
[firstpage_image] =>[orig_patent_app_number] => 500001
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/500001 | Preparations containing 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines | Jul 9, 1995 | Issued |
Array
(
[id] => 3666774
[patent_doc_number] => 05599817
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-04
[patent_title] => 'Xanthine derivatives as diuretic agents'
[patent_app_type] => 1
[patent_app_number] => 8/436220
[patent_app_country] => US
[patent_app_date] => 1995-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1650
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/599/05599817.pdf
[firstpage_image] =>[orig_patent_app_number] => 436220
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/436220 | Xanthine derivatives as diuretic agents | Jul 5, 1995 | Issued |
Array
(
[id] => 3608618
[patent_doc_number] => 05589457
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-31
[patent_title] => 'Process for the synchronization of ovulation'
[patent_app_type] => 1
[patent_app_number] => 8/498691
[patent_app_country] => US
[patent_app_date] => 1995-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4679
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/589/05589457.pdf
[firstpage_image] =>[orig_patent_app_number] => 498691
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/498691 | Process for the synchronization of ovulation | Jul 2, 1995 | Issued |
Array
(
[id] => 3623098
[patent_doc_number] => 05602105
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-11
[patent_title] => 'Cardiotropic formulation'
[patent_app_type] => 1
[patent_app_number] => 8/495298
[patent_app_country] => US
[patent_app_date] => 1995-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6603
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/602/05602105.pdf
[firstpage_image] =>[orig_patent_app_number] => 495298
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/495298 | Cardiotropic formulation | Jun 27, 1995 | Issued |
| 08/454184 | AQUEOUS PHARMACEUTICAL PREPARATIONS OF G-CSF WITH A LONG SHELF LIFE | Jun 14, 1995 | Abandoned |
Array
(
[id] => 3510597
[patent_doc_number] => 05587397
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-24
[patent_title] => 'Reduction of elevated blood lactate using twice-daily dichloroacetate'
[patent_app_type] => 1
[patent_app_number] => 8/488977
[patent_app_country] => US
[patent_app_date] => 1995-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6089
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/587/05587397.pdf
[firstpage_image] =>[orig_patent_app_number] => 488977
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/488977 | Reduction of elevated blood lactate using twice-daily dichloroacetate | Jun 7, 1995 | Issued |
Array
(
[id] => 3694834
[patent_doc_number] => 05679714
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-21
[patent_title] => 'Administration of ketamine for detoxification and treatment of tobacco addiction'
[patent_app_type] => 1
[patent_app_number] => 8/477365
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5659
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/679/05679714.pdf
[firstpage_image] =>[orig_patent_app_number] => 477365
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/477365 | Administration of ketamine for detoxification and treatment of tobacco addiction | Jun 6, 1995 | Issued |
Array
(
[id] => 4288304
[patent_doc_number] => 06268358
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Compounds for the treatment of Alzheimer\'s disease'
[patent_app_type] => 1
[patent_app_number] => 8/473712
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8440
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268358.pdf
[firstpage_image] =>[orig_patent_app_number] => 473712
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473712 | Compounds for the treatment of Alzheimer's disease | Jun 6, 1995 | Issued |
| 08/486089 | SPIRONOLACTONE AND ANGIOTENSIN II ANTAGONIST COMBINATION THERAPY FOR TREATMENT OF CONGESTIVE HEART FAILURE | Jun 6, 1995 | Abandoned |
Array
(
[id] => 3696478
[patent_doc_number] => 05661188
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-26
[patent_title] => 'Therapeutic uses for sodium 2-mercaptoethanesulphonate (mesna)'
[patent_app_type] => 1
[patent_app_number] => 8/483867
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3837
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/661/05661188.pdf
[firstpage_image] =>[orig_patent_app_number] => 483867
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/483867 | Therapeutic uses for sodium 2-mercaptoethanesulphonate (mesna) | Jun 6, 1995 | Issued |
Array
(
[id] => 3724774
[patent_doc_number] => 05681852
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-28
[patent_title] => 'Desquamation compositions'
[patent_app_type] => 1
[patent_app_number] => 8/480632
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8896
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/681/05681852.pdf
[firstpage_image] =>[orig_patent_app_number] => 480632
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/480632 | Desquamation compositions | Jun 6, 1995 | Issued |
| 08/480352 | TREATMENT OF GLOBAL ISCHEMIA | Jun 6, 1995 | Abandoned |
| 08/475990 | HALOPERIDOL ANALOGS AND THE USE THEREOF | Jun 6, 1995 | Abandoned |
Array
(
[id] => 3621400
[patent_doc_number] => 05614545
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-25
[patent_title] => 'Topical composition for treatment of blepharitis'
[patent_app_type] => 1
[patent_app_number] => 8/477089
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3237
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/614/05614545.pdf
[firstpage_image] =>[orig_patent_app_number] => 477089
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/477089 | Topical composition for treatment of blepharitis | Jun 6, 1995 | Issued |